Malcovati L - Search Results

1

Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.

Pellagatti A, Marafioti T, Paterson JC, Malcovati L, Della Porta MG, Jädersten M, Pushkaran B, George TI, Arber DA, Killick S, Giagounidis A, Hellström-Lindberg E, Cazzola M, Wainscoat JS, Boultwood J. Pellagatti A, et al. Among authors: malcovati l. Br J Haematol. 2009 Jun;146(1):86-90. doi: 10.1111/j.1365-2141.2009.07720.x. Epub 2009 May 5. Br J Haematol. 2009. PMID: 19438482 Free article.

2

Hematologic passport for athletes competing in endurance sports: a feasibility study.

Malcovati L, Pascutto C, Cazzola M. Malcovati L, et al. Haematologica. 2003 May;88(5):570-81. Haematologica. 2003. PMID: 12745277

3

Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders.

Passamonti F, Pietra D, Malabarba L, Rumi E, Della Porta MG, Malcovati L, Bonfichi M, Pascutto C, Lazzarino M, Cazzola M. Passamonti F, et al. Among authors: malcovati l. Br J Haematol. 2004 Sep;126(5):650-6. doi: 10.1111/j.1365-2141.2004.05098.x. Br J Haematol. 2004. PMID: 15327515 Free article.

4

Splenectomy for treatment of immune thrombocytopenic purpura.

Malcovati L, Della Porta MG. Malcovati L, et al. Haematologica. 2005 Jan;90(1):4. Haematologica. 2005. PMID: 15644305 No abstract available.

5

Myelodysplastic syndromes--coping with ineffective hematopoiesis.

Cazzola M, Malcovati L. Cazzola M, et al. Among authors: malcovati l. N Engl J Med. 2005 Feb 10;352(6):536-8. doi: 10.1056/NEJMp048266. N Engl J Med. 2005. PMID: 15703418 No abstract available.

6

Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.

Malcovati L, Della Porta MG, Lunghi M, Pascutto C, Vanelli L, Travaglino E, Maffioli M, Bernasconi P, Lazzarino M, Invernizzi R, Cazzola M. Malcovati L, et al. Leukemia. 2005 May;19(5):776-83. doi: 10.1038/sj.leu.2403680. Leukemia. 2005. PMID: 15789068 Clinical Trial.

7

Risk factors for Gram-negative infections in neutropenic patients.

Della Porta MG, Malcovati L. Della Porta MG, et al. Among authors: malcovati l. Haematologica. 2005 Aug;90(8):1013C. Haematologica. 2005. PMID: 16079097 No abstract available.

8

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

Malcovati L, Porta MG, Pascutto C, Invernizzi R, Boni M, Travaglino E, Passamonti F, Arcaini L, Maffioli M, Bernasconi P, Lazzarino M, Cazzola M. Malcovati L, et al. J Clin Oncol. 2005 Oct 20;23(30):7594-603. doi: 10.1200/JCO.2005.01.7038. Epub 2005 Sep 26. J Clin Oncol. 2005. PMID: 16186598

9

Outcome after allogeneic bone marrow transplantation in cytogenetic high-risk myelodysplastic syndromes and acute myeloid leukemia.

Della Porta MG, Malcovati L. Della Porta MG, et al. Among authors: malcovati l. Haematologica. 2005 Oct;90(10):1298C. Haematologica. 2005. PMID: 16219554 No abstract available.

10

Simian virus 40 and lymphoproliferative disorder.

Della Porta MG, Malcovati L. Della Porta MG, et al. Among authors: malcovati l. Haematologica. 2005 Dec;90(12):1587. Haematologica. 2005. PMID: 16330424 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters